Correction: LncRNA-SVUGP2 Suppresses Progression of Hepatocellular Carcinoma.

Jiangfeng Hu,Chenlin Song,Bensong Duan,Xiaoyan Zhang,Dongliang Li,Liang Zhu,Hengjun Gao

DOI: https://doi.org/10.18632/oncotarget.25888

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.18279.].

What problem does this paper attempt to address?

Correction: ShRNA-Targeted COMMD7 Suppresses Hepatocellular Carcinoma Growth.

Lu Zheng,Ping Liang,Jing Li,Xiao-Bing Huang,Shi-Cheng Liu,Hong-Zhi Zhao,Ke-Qiang Han,Zheng Wang

DOI: https://doi.org/10.1371/journal.pone.0214259

IF: 3.7

2019-01-01

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0045412.].
Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Jiaojiao Hao,Zhenglin Li,Changlin Zhang,Wendan Yu,Zhipeng Tang,Yixin Li,Xu Feng,Yue Gao,Quentin Liu,Wenlin Huang,Wei Guo,Wuguo Deng

DOI: https://doi.org/10.62347/suki5933

2024-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 13 in vol. 7, PMID: 28123844.].
[Corrigendum] Long non‑coding RNA LINC00238 suppresses the malignant phenotype of liver cancer by sponging miR‑522.

Hong-Gang Qian,Qiong Wu,Jian-Hui Wu,Xiu-Yun Tian,Wei Xu,Chun-Yi Hao

DOI: https://doi.org/10.3892/mmr.2024.13189

IF: 3.423

2024-01-01

Molecular Medicine Reports

Abstract:Subsequently to the publication of the above article, an interested reader drew to the authors' attention that two pairs of data panels featured in Figs. 2E and 6D, portraying the results from cell invasion and migration assay experiments, appeared to contain overlapping sections, such that data which were intended to show the results from differently performed experiments had apparently been derived from a smaller number of original sources. The authors were able to re‑examine their original data (which was also presented to the Editorial Office), and realized that errors has been made in the compilation of Fig. 2. The proposed revised version of Fig. 2, now showing the results from the 'field 1' view of the data, is shown on the next page. Note that these errors did not significantly affect either the results or the conclusions reported in this paper,.All the authors agree to the publication of this Corrigendum, and are grateful to the Editor of Molecular Medicine Reports for allowing them the opportunity to correct this error; furthermore, they apologize to the readership for any inconvenience caused. [Molecular Medicine Reports 25: 71, 2022; DOI: 10.3892/mmr.2022.12587].
Correction: LncRNA-NNT-AS1 contributes to the progression of glioma by miR-582-5p/EZH2 axis

Tonglin Pan,Min Xue

DOI: https://doi.org/10.1007/s10616-024-00636-z

IF: 2.2

Cytotechnology

Abstract:[This corrects the article DOI: 10.1007/s10616-021-00471-6.].
Corrigendum: LncRNA SOX2-OT/miR-30d-5p/PDK1 Regulates PD-L1 Checkpoint Through the mTOR Signaling Pathway to Promote Non-Small Cell Lung Cancer Progression and Immune Escape

Zhoumiao Chen,Zhao Chen,Shaohua Xu,Qiang Zhang

DOI: https://doi.org/10.3389/fgene.2022.857986

IF: 3.7

2022-03-03

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2021.674856.].

genetics & heredity
Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma

Fei Teng,Ju-Xiang Zhang,Qi-Meng Chang,Xu-Bo Wu,Wei-Guo Tang,Jian-Fa Wang,Jin-Feng Feng,Zi-Ping Zhang,Zhi-Qiu Hu

DOI: https://doi.org/10.1186/s13046-020-01780-y

2020-12-01

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA

Qi Chang Zheng,Shuai Jiang,Yu Zhe Wu,Dan Shang,Yong Zhang,Shao Bo Hu,Xiang Cheng,Chen Zhang,Ping Sun,Yang Gao,Zi Fang Song,Min Li

DOI: https://doi.org/10.3389/fbioe.2021.656268

IF: 5.7

2021-02-11

Frontiers in Bioengineering and Biotechnology

Abstract:[This corrects the article DOI: 10.3389/fbioe.2020.00512.].

multidisciplinary sciences
Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma (vol 11, 650173, 2021)

Kainan Zhang,Hui Liu,Mengsi Yu,Hui Zhao,Ning Yang,Xiaojuan Bi,Li Sun,Renyong Lin,Guodong Lü

DOI: https://doi.org/10.3389/fonc.2021.785394

IF: 4.7

2021-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.650173.].
Corrigendum: Positive Reciprocal Feedback of LncRNA ZEB1-AS1 and HIF-1α Contributes to Hypoxia–Promoted Tumorigenesis and Metastasis of Pancreatic Cancer

Yan Jin,Zhengming Zhang,Qiao Yu,Zhu Zeng,Hong Song,Xiaoxu Huang,Qi Kong,Hao Hu,Yabin Xia

DOI: https://doi.org/10.3389/fonc.2021.821077

IF: 4.7

2021-12-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.761979.].

oncology
Corrigendum: A novel LncRNA, AC091729.7 promotes sinonasal squamous cell carcinomas proliferation and invasion through binding SRSF2

Boyu Yu,Linmei Qu,Tianyi Wu,Bingrui Yan,Xuan Kan,Xuehui Zhao,Like Yang,Yushan Li,Ming Liu,Linli Tian,Yanan Sun,Qiuying Li

DOI: https://doi.org/10.3389/fonc.2024.1476128

2024-09-30

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.01575.].
Publisher Correction: Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma

Li-Na You,Qin-Wen Tai,Lin Xu,Yi Hao,Wen-Jia Guo,Qiao Zhang,Qing Tong,Heng Zhang,Wu-Kui Huang

DOI: https://doi.org/10.1038/s41417-021-00338-0

IF: 5.854

2021-04-19

Cancer Gene Therapy

Abstract:A Correction to this paper has been published: https://doi.org/10.1038/s41417-021-00338-0

oncology,genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology
Overexpression of lncRNA H19/miR-675 promotes tumorigenesis in head and neck squamous cell carcinoma: Erratum

Guo-fang Guan,De-jun Zhang,Lian-ji Wen,Ding Xin,Yan Liu,Duo-jiao Yu,Kai Su,Lin Zhu,Ying-yuan Guo,Ke Wang

DOI: https://doi.org/10.7150/ijms.73148

2022-01-01

International Journal of Medical Sciences

Abstract:[This corrects the article DOI: 10.7150/ijms.16571.].

medicine, general & internal
Corrigendum: Association of preoperative NANOG-positive circulating tumor cell levels with recurrence of hepatocellular carcinoma

Yongrong Lei,Xishu Wang,Heng Sun,Yuna Fu,Yichen Tian,Ludi Yang,Jianhua Wang,Feng Xia

DOI: https://doi.org/10.3389/fonc.2024.1438731

2024-07-10

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.601668.].
Correction: Tumor Driven by Gain-of-function HER2 H878Y Mutant is Highly Sensitive to HER2 Inhibitor.

Zexi Hu,Yong Hu,Xicheng Liu,Rongwen Xi,Aiqun Zhang,Deruo Liu,Qiang Xie,Liang Chen

DOI: https://doi.org/10.18632/oncotarget.26252

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.5221.].
Corrigendum: Downregulation of miR-135b-5p Suppresses Progression of Esophageal Cancer and Contributes to the Effect of Cisplatin

Yuzhu Di,Yanan Jiang,Xiuyun Shen,Jing Liu,Yang Gao,Huimin Cai,Xiaoli Sun,Dandan Ning,Bing Liu,Jiaji Lei,Shizhu Jin

DOI: https://doi.org/10.3389/fonc.2021.785363

IF: 4.7

2021-11-15

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.679348.].

oncology
The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4: Erratum

Liu Yang,Yang Guo,Xin Liu,Tongtong Wang,Xiangmin Tong,Kefeng Lei,Jiahui Wang,Dongsheng Huang,Qiuran Xu

DOI: https://doi.org/10.7150/jca.76866

IF: 3.9

2022-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.25569.].

oncology
Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Haibo Xing,Mengting Tong,Jing Wang,Hanqing Hu,Chongya Zhai,Chunhui Huang,Da Li

DOI: https://doi.org/10.1155/2022/9767389

2022-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2018/3195025.].
Erratum to upregulation of long noncoding RNA RAB11B-AS1 promotes tumor metastasis and predicts poor prognosis in lung cancer

Tiegang Li,Di Wu,Qun Liu,Dedong Wang,Jinbin Chen,Hongjun Zhao,Lan Zhang,Chenli Xie,Wei Zhu,Zhixu Chen,Yifeng Zhou,Soham Datta,Fuman Qiu,Lei Yang,Jiachun Lu

DOI: https://doi.org/10.21037/atm-2020-41

IF: 3.616

2020-11-01

Annals of Translational Medicine

Abstract:[This corrects the article DOI: 10.21037/atm.2020.04.52.].

oncology,medicine, research & experimental
Correction to: Zinc-finger protein 471 suppresses gastric cancer through transcriptionally repressing downstream oncogenic PLS3 and TFAP2A

Lei Cao,Shiyan Wang,Yanquan Zhang,Ka-Chun Wong,Geicho Nakatsu,Xiaohong Wang,Sunny Wong,Jiafu Ji,Jun Yu

DOI: https://doi.org/10.1038/s41388-022-02216-x

IF: 8.756

2022-04-29

Oncogene

Abstract:Oncogene, Published online: 28 April 2022; doi:10.1038/s41388-022-02216-x Correction to: Zinc-finger protein 471 suppresses gastric cancer through transcriptionally repressing downstream oncogenic PLS3 and TFAP2A

oncology,genetics & heredity,biochemistry & molecular biology,cell biology
Correction to: Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence

Junming Bi,Hongwei Liu,Wei Dong,Weibin Xie,Qingqing He,Zijian Cai,Jian Huang,Tianxin Lin

DOI: https://doi.org/10.1186/s12943-020-01265-8

IF: 37.3

2020-10-12

Molecular Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology,biochemistry & molecular biology

Correction: LncRNA-SVUGP2 Suppresses Progression of Hepatocellular Carcinoma.

Correction: ShRNA-Targeted COMMD7 Suppresses Hepatocellular Carcinoma Growth.

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

[Corrigendum] Long non‑coding RNA LINC00238 suppresses the malignant phenotype of liver cancer by sponging miR‑522.

Correction: LncRNA-NNT-AS1 contributes to the progression of glioma by miR-582-5p/EZH2 axis

Corrigendum: LncRNA SOX2-OT/miR-30d-5p/PDK1 Regulates PD-L1 Checkpoint Through the mTOR Signaling Pathway to Promote Non-Small Cell Lung Cancer Progression and Immune Escape

Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma

Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA

Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma (vol 11, 650173, 2021)

Corrigendum: Positive Reciprocal Feedback of LncRNA ZEB1-AS1 and HIF-1α Contributes to Hypoxia–Promoted Tumorigenesis and Metastasis of Pancreatic Cancer

Corrigendum: A novel LncRNA, AC091729.7 promotes sinonasal squamous cell carcinomas proliferation and invasion through binding SRSF2

Publisher Correction: Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma

Overexpression of lncRNA H19/miR-675 promotes tumorigenesis in head and neck squamous cell carcinoma: Erratum

Corrigendum: Association of preoperative NANOG-positive circulating tumor cell levels with recurrence of hepatocellular carcinoma

Correction: Tumor Driven by Gain-of-function HER2 H878Y Mutant is Highly Sensitive to HER2 Inhibitor.

Corrigendum: Downregulation of miR-135b-5p Suppresses Progression of Esophageal Cancer and Contributes to the Effect of Cisplatin

The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4: Erratum

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Erratum to upregulation of long noncoding RNA RAB11B-AS1 promotes tumor metastasis and predicts poor prognosis in lung cancer

Correction to: Zinc-finger protein 471 suppresses gastric cancer through transcriptionally repressing downstream oncogenic PLS3 and TFAP2A

Correction to: Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence